药物及药物中间体的合成、催化不对称反应、功能相变材料

[1] Sang Zhipei*,#, Wang Keren#, Shi Jian, Cheng xinfeng, Zhu Gaofeng, Wei Rongrui, Ma Qinge, Yu Lintao, Zhao Yiyang, Tan Zhenghuai*, Liu Wenmin*. Apigenin-rivastigmine hybrids as multi-target-directed ligands for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry, 2020, 187: 111958.
[2] Zhipei Sang *, 1, Keren Wang1, Jian Shi, Wenmin Liu**, Zhenghuai Tan***. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry, 2019, (178): 726-739.
[3] Zhipei Sang*, 1, Keren Wang1, Pengfei Zhang, Jian Shi, Wenmin Liu**, Zhenghuai Tan***. Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry, 2019, (180): 238-252.

河南省教育厅学术技术带头人
河南省创先争优党员之星
河南省文明教师